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Spinal myoclonus is an unusual, self-limiting, adverse event that may occur during spinal anesthesia. The exact cause 
and underlying biochemical mechanism of spinal myoclonus remain unclear. A few cases of spinal myoclonus have 
been reported after administration of intrathecal bupivacaine. We report a case in which spinal myoclonus recurred 
after two episodes of spinal anesthesia with bupivacaine at a 1-year interval in a 35-year-old woman. The myoclonus 
was acute and transient. The patient recovered completely, with no neurologic sequelae. (Korean J Anesthesiol 2010; 
59: S62-S64)
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    Spinal myoclonus is a sudden, abrupt, brief, shock-like 
involuntary movement caused by muscular contractions 
(positive myoclonus) or a sudden brief lapse of muscle 
contraction in active postural muscles (negative myoclonus, 
or asterixis) [1]. The causes of spinal myoclonus are varied 
and include tumors, infection, trauma, and degenerative 
disease. An additional cause is adverse effects of certain 
drugs, administered via neuraxial routes [2]. However, spinal 
myoclonus following spinal anesthesia is extremely rare, and 
only a few cases have been reported. Almost all reported cases 
were related to intrathecal bupivacaine. Additionally, recurrent 
spinal myoclonus after spinal anesthesia in the same person has 
not previously been reported. Here, we present a case report 
with a review of the literature.
Case Report
    A 35-year-old, 157 cm, 52 kg, woman was hospitalized for 
surgical treatment of peroneal tendonitis in her right foot. 
She had no significant medical history, allergy, or previous 
neurological disease. She underwent surgery for the same 
condition 1 year earlier at another hospital. Spinal anesthesia 
was performed and the operation was uneventful. After 
transferring to the general ward, the patient’s right leg began 
moving involuntarily. The movement was rhythmic and was 
limited to the right leg. The transient movement disappeared 
completely after 30 min, and no complication resulted. A 
specific diagnosis for the movement was not determined. The 
patient experienced no further problem. S63 www.ekja.org
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    On a preoperative visit to our hospital, she expressed no fear 
regarding spinal anesthesia and agreed to undergo spinal 
anesthesia again. 
    Premedication consisted of 2.5 mg of midazolam, administered 
intramuscularly 30 min before surgery. In the operating room, 
standard monitoring (non-invasive blood pressure, peripheral 
oxygen saturation, and electrocardiogram) was used. The 
patient was placed in the right lateral decubitus position, and 
lumbar puncture was performed without difficulty at L3-4. After 
free-flowing cerebrospinal fluid was obtained, 9 mg of heavy 
bupivacaine 0.5% (Marcaine Spinal 0.5% Heavy
Ⓡ, AstraZeneca, 
Sweden) and 0.2 mg of epinephrine were administered via 
a 25 G spinal needle. The procedure was performed without 
complication. Sensory input to T10 was blocked, and the 
surgery was completed uneventfully in approximately 50 min.
    After surgery, the patient was transferred to a recovery room. 
Approximately 100 min after administration of anesthesia, she 
began to experience bilateral, involuntary myoclonic movement 
of both legs and arms. Sensory function in her arms was intact, 
and the rhythm of the movement varied widely in rate. She was 
conscious, oriented, and calm. At that point, 2 mg of midazolam 
was administered intravenously. Approximately 10 min later, 
she was treated with 0.5 mg of oral clonazepam and 2 mg of 
IV midazolam. The myoclonic movement diminished slightly, 
but persisted. A neurology consult was obtained. There was no 
evidence of weakness or impairment of cerebellar or cranial 
nerve dysfunction. Thus, these movements were clinically 
defined as spinal myoclonus. After approximately 1 h, 0.5 mg of 
clonazepam was administered again. The myoclonic movement 
disappeared completely at 4 h after its onset. Postoperative 
laboratory findings, including serum electrolytes and glucose, 
were within normal limits. When she was examined again the 
following day, no abnormal neurologic finding was evident. 
One month later, she visited the hospital again; no recurrence of 
spinal myoclonus had occurred.
Discussion
    The present report describes an interesting case of spinal 
myoclonus that recurred after two episodes of spinal anesthesia 
with hyperbaric bupivacaine at a 1-year interval in a 35-year-
old woman. The first myoclonus occurred within 3 h of spinal 
anesthesia. The bupivacaine used in this patient was also used 
for spinal anesthesia at the other hospital. The development of 
spinal myoclonus in our patient did not appear be related to a 
spinal anesthesia technical problem. The second occurrence of 
spinal myoclonus had a more rapid onset and a longer duration, 
and a larger part of the body was involved, compared with the 
first attack. However, no complication resulted.
    Onset and duration of myoclonus vary and are not correlated 
with baricity, dose, or needle gauge in uncomplicated spinal 
anesthesia.
    In one case, 12 mg of normobaric bupivacaine 0.5% via a 
25-G spinal needle was used. Myoclonus developed on day 1 
postoperatively, and contractions disappeared completely on 
day 4 [3]. In another case, 14 mg of tetracaine with 10% dextrose 
in combination with 0.2 mg of epinephrine was injected. Spinal 
myoclonus developed approximately 7 h after administration 
of anesthesia and lasted a few hours [4]. Lin et al. [5] reported 
a patient who underwent spinal anesthesia with 2.5 ml of 0.5% 
hypobaric bupivacaine, administered via a 26-G spinal needle. 
Approximately 1 h after anesthesia, the patient began to have 
bilateral, symmetrical, rhythmic myoclonic movement in the 
lower legs. Contractions persisted for approximately 50 min, 
and resolved after recovery from spinal anesthesia.
    Myoclonus may be induced by drugs, such as local anesthetics, 
analgesics, or contrast material, administered via intrathecal 
or epidural routes. Batra et al. [6] reported a case of spinal my-
oclonus that occurred immediately after intrathecal injection 
of bupivacaine and fentanyl in a 45 day-old healthy infant. 
Onset was more rapid than in our case, and the duration was 
only 4 min. Intrathecal bupivacaine appears to be the most 
likely cause, because there was no history of a seizure disorder, 
a normal neurological examination, and unremarkable follow-
up imaging. The local anesthetic may have induced spinal cord 
irritation, resulting in spontaneous and repetitive discharges 
of the anterior horn cell groups. Some have suggested that the 
effect of bupivacaine on inhibitory neurons may have led to a 
loss of inhibitory function in the spinal cord and heightened 
irritability of the alpha motor neuron, leading to myoclonus 
[3,4]. Because our patient had no specific disease history 
and had unremarkable neurologic and laboratory findings, 
the cause of spinal myoclonus was likely spinal anesthesia 
with bupivacaine. Spinal myoclonus is an unusual and self-
limiting adverse event during the practice of spinal anesthesia, 
and usually resolves after the disappearance of the drug’s 
effect. However, in some cases, specific treatment, including 
benzodiazepines and anticonvulsants, is needed. Alfa and 
Bamgbade [7] suggested that midazolam is the benzodiazepine 
of choice for treating perioperative spinal myoclonus.
    For diagnosis, blood tests, including electrolytes, glucose, 
renal function tests, hepatic function tests, paraneoplastic 
antibody detection, and electromyography (EMG), are 
useful. EMG shows bursts >100 ms with or without rhythmic 
findings in spinal myoclonus. Electroencephalography and 
somatosensory-evoked potentials show normal findings [8]. 
MRI of the spine or brain is also useful to rule out spinal cord or 
brain abnormalities. In our patent, blood tests were performed, 
but other tests were impractical. Considering our patient’s past 
history, spinal anesthesia should not be repeated. Neither we S64 www.ekja.org
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nor the patient thought that her experience was trivial.
    In conclusion, anesthesiologists must be aware of the 
potential for this very rare phenomenon to occur as a result of 
spinal anesthesia. Also, anesthesiologists should carefully take 
past anesthetic histories and consider the recurrence when 
planning anesthetic technique for the patients who had an 
episode of spinal myoclonus. 
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